Novavax
NVAX
#5756
Rank
โ‚น100.94 B
Marketcap
โ‚น621.18
Share price
0.73%
Change (1 day)
-19.11%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of September 2025 : -โ‚น14.09 Billion

According to Novavax's latest financial reports the company has -โ‚น14.09 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-โ‚น53.52 Billion-10.33%
2023-12-31$-โ‚น59.69 Billion13.75%
2022-12-31$-โ‚น52.47 Billion100.46%
2021-12-31$-โ‚น26.18 Billion-157.06%
2020-12-31$โ‚น45.87 B-445.8%
2019-12-31$-โ‚น13.27 Billion12.97%
2018-12-31$-โ‚น11.75 Billion80.77%
2017-12-31$-โ‚น6.5 Billion1623.55%
2016-12-31$-โ‚น0.38 Billion-101.94%
2015-12-31$โ‚น19.44 B33.65%
2014-12-31$โ‚น14.55 B15.9%
2013-12-31$โ‚น12.55 B185.79%
2012-12-31$โ‚น4.39 B54.23%
2011-12-31$โ‚น2.84 B7.66%
2010-12-31$โ‚น2.64 B-18.48%
2009-12-31$โ‚น3.24 B48.45%
2008-12-31$โ‚น2.18 B-11.66%
2007-12-31$โ‚น2.47 B-40.55%
2006-12-31$โ‚น4.16 B86.33%
2005-12-31$โ‚น2.23 B55.02%
2004-12-31$โ‚น1.44 B-11.93%
2003-12-31$โ‚น1.63 B322.73%
2002-12-31$โ‚น0.38 B-70.82%
2001-12-31$โ‚น1.32 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-โ‚น25.25 Billion 79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น118.67 B-942.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น52.36 B-471.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น34.87 Billion 147.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น4.132 T-29,442.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น8.368 T-59,520.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น4.023 T-28,664.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
โ‚น0.67 B-104.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น1.903 T-13,616.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚น53.79 B-481.92%๐Ÿ‡บ๐Ÿ‡ธ USA